These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 5275018

  • 1. The treatment of skin disorders with intramuscular triamcinolone acetonide.
    Rosten M.
    N Z Med J; 1970 Oct; 72(461):253-5. PubMed ID: 5275018
    [No Abstract] [Full Text] [Related]

  • 2. [The association of aureomycin and triamcinolone acetonide for topical use in dermatology].
    Izzo L, Biondi C.
    Minerva Dermatol; 1967 Oct; 42(10):520-3. PubMed ID: 5606433
    [No Abstract] [Full Text] [Related]

  • 3. The use of intramuscular triamcinolone acetonide in allergic rhinitis and other allergic conditions.
    Siegel C.
    Curr Ther Res Clin Exp; 1965 Oct; 7(10):625-32. PubMed ID: 4954888
    [No Abstract] [Full Text] [Related]

  • 4. Intramuscular triamcinolone acetonide for supportive treatment of patients with allergic disorders.
    Medivetsky HE.
    Med Times; 1967 Nov; 95(11):1215-22. PubMed ID: 6081112
    [No Abstract] [Full Text] [Related]

  • 5. Long-term intramuscular administration of triamcinolone acetonide. Effect on the hypothalamic-pituitary-adrenal axis.
    Carson TE, Daane TA, Weinstein RL.
    Arch Dermatol; 1975 Dec; 111(12):1585-7. PubMed ID: 1200663
    [Abstract] [Full Text] [Related]

  • 6. Aquagenic pruritus: effective treatment with intramuscular triamcinolone acetonide.
    Carson TE.
    Cutis; 1991 Nov; 48(5):382. PubMed ID: 1764961
    [No Abstract] [Full Text] [Related]

  • 7. Intramuscular triamcinolone acetonide for the treatment of allergic and cutaneous diseases: report of 582 patients.
    Sherwood H, Epstein J, Maurer ML, Blau S, Kanof NB, Zucker A, Chemris W.
    Curr Ther Res Clin Exp; 1967 Mar; 9(3):114-30. PubMed ID: 4963173
    [No Abstract] [Full Text] [Related]

  • 8. [Provocation of abnormal uterine hemorrhages and subcutaneous hematomas by using triamcinolone acetonide in allergic patients].
    Mathov E, Grad P, Scaglia H.
    Prensa Med Argent; 1971 Jun; 58(16):826-9. PubMed ID: 5094412
    [No Abstract] [Full Text] [Related]

  • 9. [Our therapeutic dermatologic experience in the use of the new triamcinolone compounds in intralesional infiltration].
    Brañas G.
    Arch Argent Dermatol; 1966 Jun; 16(1):34-44. PubMed ID: 5987841
    [No Abstract] [Full Text] [Related]

  • 10. [The indication area of triamcinolone acetonide 40 mg in dermatologic practice. Report of 12000 cases].
    Bleckmann FG.
    Med Welt; 1976 Jul 30; 27(31):1473-4. PubMed ID: 785153
    [No Abstract] [Full Text] [Related]

  • 11. [On treatment of skin diseases with triamcinolone hexacetonide].
    Schnellen B.
    Z Allgemeinmed; 1969 Feb 20; 45(5):214-6. PubMed ID: 4238975
    [No Abstract] [Full Text] [Related]

  • 12. [The use of Kenacort-A-tincture in dermatologic disorders].
    Kroepfli P.
    Schweiz Rundsch Med Prax; 1972 Apr 18; 61(16):532-5. PubMed ID: 5021823
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of nail psoriasis with Volon A tincture].
    Janke D.
    Z Haut Geschlechtskr; 1969 Oct 01; 44(19):873-6. PubMed ID: 5382294
    [No Abstract] [Full Text] [Related]

  • 14. [Hagerman's Triamcinolone Acetonide tincture in psoriasis vulgaris].
    Proppe A, Paetzold OH.
    Med Welt; 1968 Mar 09; 10():627-36. PubMed ID: 5706210
    [No Abstract] [Full Text] [Related]

  • 15. [Clinical experiences in dermatology with a new psychoagent].
    Beltrani G, Fuga G.
    Clin Ter; 1969 Mar 31; 48(6):525-44. PubMed ID: 4252268
    [No Abstract] [Full Text] [Related]

  • 16. Dimethyl sulfoxide as a vehicle for corticosteroids. A comparison with the occlusive dressing technique.
    Groel JT.
    Arch Dermatol; 1968 Feb 31; 97(2):110-4. PubMed ID: 5636042
    [No Abstract] [Full Text] [Related]

  • 17. Parenteral long-acting corticosteroids: effect on hypothalamic-pituitary-adrenal function.
    Mikhail GR, Sweet LC, Mellinger RC.
    Ann Allergy; 1973 Jul 31; 31(7):337-43. PubMed ID: 4352151
    [No Abstract] [Full Text] [Related]

  • 18. Clinical evaluation of an intramuscularly administered steroid (triamcinolone acetonide).
    Demos CH, Maurer ML.
    J Med Soc N J; 1968 Oct 31; 65(10):533-6. PubMed ID: 5273164
    [No Abstract] [Full Text] [Related]

  • 19. [Effect of 0,015 per cent Triamcinolone acetonide cream and 1,0 per cent Hydrocortisone acetate cream in hemi-experiments].
    Wysocki R.
    Ther Ggw; 1972 Apr 31; 111(4):565 passim. PubMed ID: 5029718
    [No Abstract] [Full Text] [Related]

  • 20. Systemic steroid therapy with intramuscularly injected triamcinolone.
    Arnold HL.
    South Med J; 1978 Feb 31; 71(2):102-7. PubMed ID: 622614
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.